We Have Made Advances
Over 60% of new drug candidates are poorly water soluble. Luminus has a novel platform to address the solubility issues, reducing the toxicity and increasing the efficacy.
We believe our platform has unrealized potential. Together we are improving therapies to treat cancer, epilepsy, pain, and burns, and others. The drug can cross the blood brain barrier and actively target cancer cells, reducing human suffering and saving lives.